Stock comparison
Medtronic
Summit Therapeutics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MDT
Medtronic
Market cap
$97.84B
Sector
Healthcare
SMMT
Summit Therapeutics
Market cap
$13.08B
Sector
Healthcare
Overall winner
Medtronic MDT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MDT | SMMT | Winner |
|---|---|---|---|
| Warren Buffett | 50C | 9F | MDT |
| Benjamin Graham | 57C | 40D | MDT |
| Philip Fisher |
Side-by-side metrics
| Metric | MDT | SMMT |
|---|---|---|
| Market cap | $97.84B | $13.08B |
| P/E (TTM) | 21.2x | - |
| EV/EBIT | 21.0x | - |
| ROIC (TTM) | 6.43% | -2.48% |
| Gross margin | 61.95% | 0.0% |
| Net margin | 13.0% | 0.0% |
| Revenue CAGR 5y | 2.73% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MDT leads on
- ROIC (TTM)6.43%vs -2.48%+103%
- Gross margin61.95%vs 0.0%+100%
- Net margin13.0%vs 0.0%+100%
- Dividend yield3.73%vs 0.0%
More like SMMT
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.